Implications of the FDA approval of PCSK9 inhibitors and FOURIER results for contemporary cardiovascular practice: An NCDR Research to Practice (R2P) project.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Hess, PL; Kennedy, K; Cowherd, M; Virani, SS; Masoudi, FA; Navar, AM; Yeh, RW; Ho, PM; Maddox, TM

Published Date

  • January 2018

Published In

Volume / Issue

  • 195 /

Start / End Page

  • 151 - 152

PubMed ID

  • 29224643

Pubmed Central ID

  • 29224643

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2017.09.004

Language

  • eng

Conference Location

  • United States